TRI-611

TRI-611 · TRIANA Biomedicines, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRI-611, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC [Phase 1, Phase 2]